Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
Glioma was the most common type of intracranial malignant tumor. Even after standard treatment, the recurrence and malignant progression of lower-grade gliomas (LGGs) were almost inevitable. The overall survival (OS) of patients with LGG varied widely, making it critical for prognostic prediction.